News

San Diego-based ChemBridge is a global discovery chemistry company providing small molecule screening compound libraries, specialty building blocks for organic synthesis and custom chemistry services. Through this collaboration,

Reportedly, Pantarhei now has secured backing from international private equity investors. Reuters quoted Pantarhei Bioscience director (and former Organon executive) Herjan Coeling Bennink as telling the Dutch Financieele

This is despite the fact that biotech drugs are twice as likely to gain US approval compared to traditional chemical drugs. Reportedly, the study which was conducted from

The idea is to work closely with external medical researchers up until the launch of a new drug which will allow GSK to tap their expertise in return

Glycosan develops, manufactures, and markets proprietary biocompatible hydrogels that mimic the extracellular matrix (ECM) that holds cells together in tissues and organs and performs many other important functions.

The study has raised researchers’ hopes of using bisphosphonates, which are indicated to stall the loss of bone mass, to help prevent cancer in healthy people, reuters.com reported.

Life Sciences organizations have to cut the cost, time and complexity of bringing safe and effective products to market and at the same time must also comply with

General and administrative expenses were $1,247, 51% higher than $825,503 in the three months ended 31 December 2009. Selling expenses in the amount of $362,071 incurred during the

GeneSightRx will now measure and analyze 50 clinically important genetic variants of six genes that affect patients’ response to medications prescribed in psychiatric medicine. The enhanced six-gene Web-based